Global Targeted Cancer Therapy Market Growth (Status and Outlook) 2025-2031

June 2025 | 137 pages | ID: GC259AA7B8E7EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Targeted Cancer Therapy market size is predicted to grow from US$ 128420 million in 2025 to US$ 201430 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

Targeted Therapies: Personalized cancer treatment drugs are designed to target specific molecules or pathways that play a critical role in the growth and spread of cancer cells. Unlike traditional chemotherapy, which can affect both healthy and cancerous cells, targeted therapies are intended to be more selective, focusing on cancer cells while sparing healthy tissue.

Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer?s molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual?s specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.

LPI (LP Information)' newest research report, the ?Targeted Cancer Therapy Industry Forecast? looks at past sales and reviews total world Targeted Cancer Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Cancer Therapy sales for 2025 through 2031. With Targeted Cancer Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Cancer Therapy industry.

This Insight Report provides a comprehensive analysis of the global Targeted Cancer Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Cancer Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Targeted Cancer Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Cancer Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Cancer Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Cancer Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Kinase Inhibitors
  • Monoclonal Antibodies
  • PARP Inhibitors
  • Other
Segmentation by Application:
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood-related Cancer
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AbbVie
  • Johnson & Johnson
  • Novartis
  • Gilead Sciences
  • Roche
  • Bristol-Myers Squibb
  • Amgen
  • AstraZeneca
  • Merck & Co
  • Takeda
  • Merck KGaA
  • Seagen
  • Eli Lilly
  • Ono Pharmaceutical
  • Pfizer
  • GSK
  • Exelixis
  • Regeneron
  • Innovent
  • Hengrui Medicine
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Targeted Cancer Therapy Market Size (2020-2031)
  2.1.2 Targeted Cancer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Targeted Cancer Therapy by Country/Region (2020, 2024 & 2031)
2.2 Targeted Cancer Therapy Segment by Type
  2.2.1 Kinase Inhibitors
  2.2.2 Monoclonal Antibodies
  2.2.3 PARP Inhibitors
  2.2.4 Other
2.3 Targeted Cancer Therapy Market Size by Type
  2.3.1 Targeted Cancer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
2.4 Targeted Cancer Therapy Segment by Application
  2.4.1 Lung Cancer
  2.4.2 Breast Cancer
  2.4.3 Prostate Cancer
  2.4.4 Blood-related Cancer
  2.4.5 Other
2.5 Targeted Cancer Therapy Market Size by Application
  2.5.1 Targeted Cancer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)

3 TARGETED CANCER THERAPY MARKET SIZE BY PLAYER

3.1 Targeted Cancer Therapy Market Size Market Share by Player
  3.1.1 Global Targeted Cancer Therapy Revenue by Player (2020-2025)
  3.1.2 Global Targeted Cancer Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Targeted Cancer Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TARGETED CANCER THERAPY BY REGION

4.1 Targeted Cancer Therapy Market Size by Region (2020-2025)
4.2 Global Targeted Cancer Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted Cancer Therapy Market Size Growth (2020-2025)
4.4 APAC Targeted Cancer Therapy Market Size Growth (2020-2025)
4.5 Europe Targeted Cancer Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted Cancer Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Targeted Cancer Therapy Market Size by Country (2020-2025)
5.2 Americas Targeted Cancer Therapy Market Size by Type (2020-2025)
5.3 Americas Targeted Cancer Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Targeted Cancer Therapy Market Size by Region (2020-2025)
6.2 APAC Targeted Cancer Therapy Market Size by Type (2020-2025)
6.3 APAC Targeted Cancer Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Targeted Cancer Therapy Market Size by Country (2020-2025)
7.2 Europe Targeted Cancer Therapy Market Size by Type (2020-2025)
7.3 Europe Targeted Cancer Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Targeted Cancer Therapy by Region (2020-2025)
8.2 Middle East & Africa Targeted Cancer Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted Cancer Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TARGETED CANCER THERAPY MARKET FORECAST

10.1 Global Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.1.1 Global Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Targeted Cancer Therapy Forecast
  10.1.3 APAC Targeted Cancer Therapy Forecast
  10.1.4 Europe Targeted Cancer Therapy Forecast
  10.1.5 Middle East & Africa Targeted Cancer Therapy Forecast
10.2 Americas Targeted Cancer Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Targeted Cancer Therapy Forecast
  10.2.2 Canada Market Targeted Cancer Therapy Forecast
  10.2.3 Mexico Market Targeted Cancer Therapy Forecast
  10.2.4 Brazil Market Targeted Cancer Therapy Forecast
10.3 APAC Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.3.1 China Targeted Cancer Therapy Market Forecast
  10.3.2 Japan Market Targeted Cancer Therapy Forecast
  10.3.3 Korea Market Targeted Cancer Therapy Forecast
  10.3.4 Southeast Asia Market Targeted Cancer Therapy Forecast
  10.3.5 India Market Targeted Cancer Therapy Forecast
  10.3.6 Australia Market Targeted Cancer Therapy Forecast
10.4 Europe Targeted Cancer Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Targeted Cancer Therapy Forecast
  10.4.2 France Market Targeted Cancer Therapy Forecast
  10.4.3 UK Market Targeted Cancer Therapy Forecast
  10.4.4 Italy Market Targeted Cancer Therapy Forecast
  10.4.5 Russia Market Targeted Cancer Therapy Forecast
10.5 Middle East & Africa Targeted Cancer Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Targeted Cancer Therapy Forecast
  10.5.2 South Africa Market Targeted Cancer Therapy Forecast
  10.5.3 Israel Market Targeted Cancer Therapy Forecast
  10.5.4 Turkey Market Targeted Cancer Therapy Forecast
10.6 Global Targeted Cancer Therapy Forecast by Type (2026-2031)
10.7 Global Targeted Cancer Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Targeted Cancer Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Targeted Cancer Therapy Product Offered
  11.1.3 AbbVie Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Targeted Cancer Therapy Product Offered
  11.2.3 Johnson & Johnson Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Targeted Cancer Therapy Product Offered
  11.3.3 Novartis Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
  11.4.1 Gilead Sciences Company Information
  11.4.2 Gilead Sciences Targeted Cancer Therapy Product Offered
  11.4.3 Gilead Sciences Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Gilead Sciences Main Business Overview
  11.4.5 Gilead Sciences Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche Targeted Cancer Therapy Product Offered
  11.5.3 Roche Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
  11.6.1 Bristol-Myers Squibb Company Information
  11.6.2 Bristol-Myers Squibb Targeted Cancer Therapy Product Offered
  11.6.3 Bristol-Myers Squibb Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bristol-Myers Squibb Main Business Overview
  11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
  11.7.1 Amgen Company Information
  11.7.2 Amgen Targeted Cancer Therapy Product Offered
  11.7.3 Amgen Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Amgen Main Business Overview
  11.7.5 Amgen Latest Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca Targeted Cancer Therapy Product Offered
  11.8.3 AstraZeneca Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AstraZeneca Main Business Overview
  11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
  11.9.1 Merck & Co Company Information
  11.9.2 Merck & Co Targeted Cancer Therapy Product Offered
  11.9.3 Merck & Co Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck & Co Main Business Overview
  11.9.5 Merck & Co Latest Developments
11.10 Takeda
  11.10.1 Takeda Company Information
  11.10.2 Takeda Targeted Cancer Therapy Product Offered
  11.10.3 Takeda Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Takeda Main Business Overview
  11.10.5 Takeda Latest Developments
11.11 Merck KGaA
  11.11.1 Merck KGaA Company Information
  11.11.2 Merck KGaA Targeted Cancer Therapy Product Offered
  11.11.3 Merck KGaA Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Merck KGaA Main Business Overview
  11.11.5 Merck KGaA Latest Developments
11.12 Seagen
  11.12.1 Seagen Company Information
  11.12.2 Seagen Targeted Cancer Therapy Product Offered
  11.12.3 Seagen Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Seagen Main Business Overview
  11.12.5 Seagen Latest Developments
11.13 Eli Lilly
  11.13.1 Eli Lilly Company Information
  11.13.2 Eli Lilly Targeted Cancer Therapy Product Offered
  11.13.3 Eli Lilly Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Eli Lilly Main Business Overview
  11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
  11.14.1 Ono Pharmaceutical Company Information
  11.14.2 Ono Pharmaceutical Targeted Cancer Therapy Product Offered
  11.14.3 Ono Pharmaceutical Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Ono Pharmaceutical Main Business Overview
  11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
  11.15.1 Pfizer Company Information
  11.15.2 Pfizer Targeted Cancer Therapy Product Offered
  11.15.3 Pfizer Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Pfizer Main Business Overview
  11.15.5 Pfizer Latest Developments
11.16 GSK
  11.16.1 GSK Company Information
  11.16.2 GSK Targeted Cancer Therapy Product Offered
  11.16.3 GSK Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 GSK Main Business Overview
  11.16.5 GSK Latest Developments
11.17 Exelixis
  11.17.1 Exelixis Company Information
  11.17.2 Exelixis Targeted Cancer Therapy Product Offered
  11.17.3 Exelixis Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Exelixis Main Business Overview
  11.17.5 Exelixis Latest Developments
11.18 Regeneron
  11.18.1 Regeneron Company Information
  11.18.2 Regeneron Targeted Cancer Therapy Product Offered
  11.18.3 Regeneron Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Regeneron Main Business Overview
  11.18.5 Regeneron Latest Developments
11.19 Innovent
  11.19.1 Innovent Company Information
  11.19.2 Innovent Targeted Cancer Therapy Product Offered
  11.19.3 Innovent Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Innovent Main Business Overview
  11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
  11.20.1 Hengrui Medicine Company Information
  11.20.2 Hengrui Medicine Targeted Cancer Therapy Product Offered
  11.20.3 Hengrui Medicine Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Hengrui Medicine Main Business Overview
  11.20.5 Hengrui Medicine Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION




LIST OF TABLES

Table 1. Targeted Cancer Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Targeted Cancer Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Kinase Inhibitors
Table 4. Major Players of Monoclonal Antibodies
Table 5. Major Players of PARP Inhibitors
Table 6. Major Players of Other
Table 7. Targeted Cancer Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Targeted Cancer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
Table 10. Targeted Cancer Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Targeted Cancer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)
Table 13. Global Targeted Cancer Therapy Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Targeted Cancer Therapy Revenue Market Share by Player (2020-2025)
Table 15. Targeted Cancer Therapy Key Players Head office and Products Offered
Table 16. Targeted Cancer Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Targeted Cancer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Targeted Cancer Therapy Market Size Market Share by Region (2020-2025)
Table 21. Global Targeted Cancer Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Targeted Cancer Therapy Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Targeted Cancer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Targeted Cancer Therapy Market Size Market Share by Country (2020-2025)
Table 25. Americas Targeted Cancer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
Table 27. Americas Targeted Cancer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)
Table 29. APAC Targeted Cancer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Targeted Cancer Therapy Market Size Market Share by Region (2020-2025)
Table 31. APAC Targeted Cancer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Targeted Cancer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Targeted Cancer Therapy Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Targeted Cancer Therapy Market Size Market Share by Country (2020-2025)
Table 35. Europe Targeted Cancer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Targeted Cancer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Targeted Cancer Therapy Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Targeted Cancer Therapy Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Targeted Cancer Therapy Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Targeted Cancer Therapy
Table 41. Key Market Challenges & Risks of Targeted Cancer Therapy
Table 42. Key Industry Trends of Targeted Cancer Therapy
Table 43. Global Targeted Cancer Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Targeted Cancer Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Targeted Cancer Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Targeted Cancer Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. AbbVie Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 48. AbbVie Targeted Cancer Therapy Product Offered
Table 49. AbbVie Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. AbbVie Main Business
Table 51. AbbVie Latest Developments
Table 52. Johnson & Johnson Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 53. Johnson & Johnson Targeted Cancer Therapy Product Offered
Table 54. Johnson & Johnson Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Novartis Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 58. Novartis Targeted Cancer Therapy Product Offered
Table 59. Novartis Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Gilead Sciences Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 63. Gilead Sciences Targeted Cancer Therapy Product Offered
Table 64. Gilead Sciences Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Gilead Sciences Main Business
Table 66. Gilead Sciences Latest Developments
Table 67. Roche Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 68. Roche Targeted Cancer Therapy Product Offered
Table 69. Roche Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Targeted Cancer Therapy Product Offered
Table 74. Bristol-Myers Squibb Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Bristol-Myers Squibb Main Business
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Amgen Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 78. Amgen Targeted Cancer Therapy Product Offered
Table 79. Amgen Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. AstraZeneca Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 83. AstraZeneca Targeted Cancer Therapy Product Offered
Table 84. AstraZeneca Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Merck & Co Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 88. Merck & Co Targeted Cancer Therapy Product Offered
Table 89. Merck & Co Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Merck & Co Main Business
Table 91. Merck & Co Latest Developments
Table 92. Takeda Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 93. Takeda Targeted Cancer Therapy Product Offered
Table 94. Takeda Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Merck KGaA Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 98. Merck KGaA Targeted Cancer Therapy Product Offered
Table 99. Merck KGaA Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Merck KGaA Main Business
Table 101. Merck KGaA Latest Developments
Table 102. Seagen Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 103. Seagen Targeted Cancer Therapy Product Offered
Table 104. Seagen Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Seagen Main Business
Table 106. Seagen Latest Developments
Table 107. Eli Lilly Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 108. Eli Lilly Targeted Cancer Therapy Product Offered
Table 109. Eli Lilly Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Latest Developments
Table 112. Ono Pharmaceutical Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 113. Ono Pharmaceutical Targeted Cancer Therapy Product Offered
Table 114. Ono Pharmaceutical Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Ono Pharmaceutical Main Business
Table 116. Ono Pharmaceutical Latest Developments
Table 117. Pfizer Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 118. Pfizer Targeted Cancer Therapy Product Offered
Table 119. Pfizer Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. GSK Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 123. GSK Targeted Cancer Therapy Product Offered
Table 124. GSK Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. GSK Main Business
Table 126. GSK Latest Developments
Table 127. Exelixis Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 128. Exelixis Targeted Cancer Therapy Product Offered
Table 129. Exelixis Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Exelixis Main Business
Table 131. Exelixis Latest Developments
Table 132. Regeneron Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 133. Regeneron Targeted Cancer Therapy Product Offered
Table 134. Regeneron Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Regeneron Main Business
Table 136. Regeneron Latest Developments
Table 137. Innovent Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 138. Innovent Targeted Cancer Therapy Product Offered
Table 139. Innovent Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140. Innovent Main Business
Table 141. Innovent Latest Developments
Table 142. Hengrui Medicine Details, Company Type, Targeted Cancer Therapy Area Served and Its Competitors
Table 143. Hengrui Medicine Targeted Cancer Therapy Product Offered
Table 144. Hengrui Medicine Targeted Cancer Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Hengrui Medicine Main Business
Table 146. Hengrui Medicine Latest Developments

LIST OF FIGURES

Figure 1. Targeted Cancer Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Cancer Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Targeted Cancer Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Targeted Cancer Therapy Sales Market Share by Country/Region (2024)
Figure 8. Targeted Cancer Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Targeted Cancer Therapy Market Size Market Share by Type in 2024
Figure 10. Targeted Cancer Therapy in Lung Cancer
Figure 11. Global Targeted Cancer Therapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 12. Targeted Cancer Therapy in Breast Cancer
Figure 13. Global Targeted Cancer Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 14. Targeted Cancer Therapy in Prostate Cancer
Figure 15. Global Targeted Cancer Therapy Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 16. Targeted Cancer Therapy in Blood-related Cancer
Figure 17. Global Targeted Cancer Therapy Market: Blood-related Cancer (2020-2025) & ($ millions)
Figure 18. Targeted Cancer Therapy in Other
Figure 19. Global Targeted Cancer Therapy Market: Other (2020-2025) & ($ millions)
Figure 20. Global Targeted Cancer Therapy Market Size Market Share by Application in 2024
Figure 21. Global Targeted Cancer Therapy Revenue Market Share by Player in 2024
Figure 22. Global Targeted Cancer Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Targeted Cancer Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Targeted Cancer Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Targeted Cancer Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Targeted Cancer Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Targeted Cancer Therapy Value Market Share by Country in 2024
Figure 28. United States Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Targeted Cancer Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Targeted Cancer Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Targeted Cancer Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Targeted Cancer Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Targeted Cancer Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Targeted Cancer Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Targeted Cancer Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Targeted Cancer Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Targeted Cancer Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Targeted Cancer Therapy Market Size 2026-2031 ($ millions)